Document:

COMPENSATION
COMMITTEE CHARTER

    OF

    NF
ENERGY SAVING CORPORATION

    

    
      	
              I. 

            	
              PURPOSE
      OF COMMITTEE

            

    

     

    The
purpose of the Compensation Committee (the “Committee’’) of the Board of
Directors (the “Board’’) of NF Energy Saving Corporation (“NFES’’) is to assist
the Board in carrying out its responsibilities with respect to:

     

    
      	
               
      

            	
              ·

            	
              Oversight
      of the development, implementation, and effectiveness of NFES’s
      compensation philosophy, policies, and strategies which are designed to
      support the business objectives of NFES by attracting, retaining,
      rewarding, and motivating the technical and entrepreneurial skills and
      talent needed to achieve those
objectives.

            

    

     

    
      	
               
      

            	
              ·

            	
              Oversee
      and assure regulatory compliance and reporting requirements with respect
      to compensation or related matters.

            

    

     

    
      	
              II. 

            	
              COMMITTEE
      MEMBERSHIP

            

    

     

    The
Committee shall be comprised of at least two members of the Board, each of whom
shall serve for such term or terms as the Board may determine, and shall be
“independent’’ according to the listing standards of the NYSE AMEX (“AMEX”) and
the rules and regulations of the Securities and Exchange Commission (“SEC”), as
amended from time to time.

     

    Notwithstanding
the preceding paragraph, if the Committee is comprised of at least three
members, one member of the Board who is not defined as “independent,” and is not
a current officer or employee or an immediate family member of such person, may
be appointed to the Committee, if the Board determines that it is an exceptional
and limited circumstance and that membership of such person on the Committee is
required by the best interests of NFES and its shareholders, and the Board makes
appropriate disclosure in the next annual meeting proxy statement (or in the
next annual report of NFES on SEC Form 10-K or equivalent) subsequent to such
determination, concerning the nature of the relationship and the reasons for
that determination. A member of the Board appointed to the Committee pursuant to
this exception may not serve for in excess of two years.

     

    Unless a
chair is elected by the Board, the members of the Committee shall designate a
chair by majority vote of the full Committee membership.

     

    Determinations
of independence shall be made by the Board as the Board interprets such
qualifications in its business judgment and in accordance with applicable law
and regulation and SEC and AMEX rules and standards.

     

    
      
         

      

      
        - Page 1
-

        
          

        

      

      
         

      

    

     

    
      	
              III. 

            	
              ORGANIZATION

            

    

     

    The
Committee will meet at least two times each year or more frequently as it deems
necessary or appropriate to carry out its duties and
responsibilities.

     

    The
Chairman shall, in consultation with management and other Committee members, set
the agenda for and preside at meetings of the Committee. The Chairman shall
designate an individual to record and keep minutes of all Committee
meetings.

     

    The
Committee may invite such members of management to its meetings as it may deem
desirable or appropriate, consistent with the maintenance of the confidentiality
of compensation discussions.

     

    
      	
              IV. 

            	
              COMMITTEE
      DUTIES AND RESPONSIBILITIES

            

    

     

    The
following are the duties and responsibilities of the Committee:

     

    
      	
            	
              A.

            	
              Approve
      NFES’s employee and director compensation plans, including any new equity
      compensation plans or material change to an existing equity compensation
      plans, and oversee the administration of these
  plans.

            

    

     

    
      	
            	
              B.

            	
              Evaluate
      the CEO’s performance in light of Board approved goals and objectives, and
      determine and approve the CEO’s equity and non-equity compensation,
      including salary, bonus, and
incentives.

            

    

     

    
      	
            	
              C.

            	
              Taking
      into account the recommendations of the CEO, evaluate the performance of
      other senior executive in light of approved goals and objectives, and
      determine and approve their equity and non-equity compensation, including
      salary, bonus, and incentives.

            

    

     

    
      	
            	
              D.

            	
              Approve,
      or delegate where appropriate, all grants of equity-based
      awards.

            

    

     

    
      	
            	
              E.

            	
              Review
      annually and approve:

            

    

     

    
      	
               
      

            	
              ·

            	
              Benefits
      and perquisites provided to NFES’s executives or other senior management
      members (where appropriate).

            

    

     

    
      	
               
      

            	
              ·

            	
              Employment
      agreements, severance arrangements and change in control agreements and
      provisions relating to NFES’s executives or other senior management
      members (where appropriate).

            

    

     

    
      	
            	
              F.

            	
              Prepare
      any report on executive compensation or related issue, as required of the
      Committee by the rules and regulations of the
  SEC.

            

    

     

    
      	
            	
              G.

            	
              Engage
      outside advisors, as appropriate, to advise the Committee on compensation
      matters.

            

    

     

    
      
         

      

      
        - Page 2
-

        
          

        

      

      
         

      

    

     

     

    
      	
            	
              H.

            	
              Report
      to the Board on a regular and timely basis, the actions taken by the
      Committee.

            

    

     

    
      	
               
      

            	
              I.

            	
              To
      discharge any other duties or responsibilities delegated to the Committee
      by the Board from time to time.

            

    

     

    
      	
              V. 

            	
              COMMITTEE
      REPORTS

            

    

     

    The
Committee shall prepare the following reports and provide them to the
Board:

     

    
      	
            	
              A.

            	
              A
      Compensation Committee Report on Executive Compensation as required by the
      SEC to be included in NFES’s annual proxy statement, in accordance with
      applicable SEC rules and
regulations.

            

    

     

    
      	
            	
              B.

            	
              A
      summary of the actions taken at each Committee
  meeting.

            

    

     

    
      	
              VI. 

            	
              RESOURCES
      AND AUTHORITY OF THE COMMITTEE

            

    

     

    The
Committee shall have direct access to, and complete and open communication with,
senior management and may obtain advice and assistance from internal legal,
accounting, and other advisors to assist it. In performing its functions, the
Committee is entitled to rely on the findings of fact, advice, reports and
opinions of management as well as legal, accounting and other advisors retained
by NFES  The Committee may retain, if appropriate, independent legal,
accounting, and other advisors to assist it, and may determine the compensation
of such advisors, and NFES shall be responsible for any costs or expenses so
incurred.

     

     

     

     

    
      
         

      

      
        - Page 3
-EXHIBIT
10.1

    

    CONVERTIBLE NOTE
AGREEMENT

    

    THIS CONVERTIBLE NOTE
AGREEMENT (this “Agreement”) is entered into as
of the __ day of September 2009, by and between Neonode, Inc., a Delaware
Company (the “Company”),
and each of the entities set forth in Exhibit
A hereto (each, an “Investor”; and collectively,
the “Investors”).

    

    WHEREAS, the Company requires
an infusion of funds in order to finance the operations of the Company as set
forth herein; and

    

    WHEREAS, the Investors are
willing to make available a convertible loan to the Company on the terms and
conditions set forth in this Agreement.

    

    NOW, THEREFORE, the parties
hereto hereby agree as follows:

    

    1.           Convertible
Loan.

    

    1.1           Each
of the Investors agrees to lend to the Company the amount set forth opposite its
name in Exhibit
A hereto (the “Investment Amount”), for an
aggregate amount of $1,250,000 hereunder (the “Loan”), subject to the terms
and conditions of this Agreement.

    

    1.2           Each
of the Investors will transfer its respective Investment Amount to the Company,
in accordance with the wire transfer instructions provided in writing by the
Company to the Investors, on the first business day following the approval of
this Agreement by the Company’s Board of Directors (the “Closing”).  At the
Closing, the Company will deliver to each of the Investors a Note substantially
as set forth in Exhibit
B.

    

    1.3           The
Loan will bear interest at a rate of 7% per year.  The accrued
interest will be payable June 30th and
December 31st each
year. The accrued interest will be payable upon repayment of the
Loan.

    

    1.4           Subject
to Section 2 below, the Loan and accrued interest will be repaid on or prior to
December 31, 2010 (the “Due
Date”). Without derogating from the provisions of Section 2 below, in the
event that the Investment Amount and accrued interest shall not be repaid by the
Company by the Due Date and the Investor has not converted the Investment Amount
pursuant to Section 2 below the Investor’s sole remedy for such non payment
shall be the payment of additional interest at a rate of 1% per
month.

    

    1.5           As
security for the repayment of the Loan and accrued interest when due, the
Company hereby grants the Investors a security interest in the intellectual
property owned by the Company.  The security interest in the Company’s
intellectual property shall terminate upon either (a) the Company’s complete
repayment of the Loan and accrued interest, or (b) conversion of the aggregate
Investment Amount into the Restricted Shares.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    1.6           Grant of
Warrant.         Simultaneously
with the execution of this Agreement, the Company shall deliver to each Lender a
Warrant Agreement (the “Warrant
Agreement”) between each Lender and the Company substantially in the form
attached hereto as Schedule 1.6
providing the Lenders with a right to purchase fully-paid and
non-assessable restricted shares of common stock of the Company, at a price of
$0.04 per share, (the “Warrant
Shares”). In case the Company borrows additional amounts from the Lenders
under this Agreement, then the Company shall issue additional Warrant Agreements
to each Lender as specified above.

    

    2.           Conversion

    

    2.1           Optional Conversion.
Without derogating from the provisions of Section 3 below, each of the Investors
shall have at any time prior to the repayment of such Investor’s Investment
Amount the option to convert its portion of the Investment Amount into
fully-paid and non-assessable restricted shares of common stock of the Company,
at a price of $0.02 per share, (the “Restricted
Shares”).

    

    2.2           Adjustment
of Conversion Price.        Upon issuance of
additional common stock of the Company at a price per share less than $0.02 per
share at a subsequent round of financing prior to the repayment of the
Investment Amount, the conversion price for the Restricted Shares will be
reduced, for no additional consideration, to an amount equal to the price per
share paid for the common stock of the Company at such subsequent financing
round.

    

    2.3           The
Company shall, promptly upon any conversion of any Investor’s Investment Amount,
issue and deliver to such Investor a certificate representing the number of
shares of the Restricted Shares to which such Investor shall be entitled upon
conversion of such Investor’s Investment Amount (bearing such legends as are
required under applicable law, in the opinion of counsel of the
Company).

    

    3.           Acceleration of
Repayment.

    

    The
Investment Amount will become, in the Investors sole discretion, repayable upon
the occurrence of an Event of Acceleration (as defined below) that occurs prior
to the conversion of the Investment Amount under Section 2 above. For the
purposes of this Section 3, an “Event of Acceleration” shall
be deemed to exist upon the occurrence of any of the following:  (a)
the Company files a petition in bankruptcy, files a petition seeking any
reorganization, arrangement, composition, or similar relief under any law
regarding insolvency or relief for debtors, or makes an assignment for the
benefit of creditors; (b) a receiver, trustee, or similar officer is appointed
for the business or a significant part of the property of the Company, and such
appointments are not stayed, enjoined, or discharged within forty five (45) days
from their commencement; (c) any involuntary petition or proceeding under
bankruptcy or insolvency laws is instituted against the Company, and such
actions are not stayed, enjoined, or discharged within forty five (45) days from
their commencement;  (d) the Company adopts a resolution for
discontinuance of its business or for its liquidation, dissolution or
winding-up; or (e)  a sale of all or substantially all of the assets of the
Company.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    

    4.           Information on the Company;
Legal Proceedings

    4.1           Information on the
Company. Each Investor has been furnished with or has had access at the
EDGAR Website of the SEC to the Company's Form 10-K filed on April 15, 2009 for
the fiscal year ended December 31, 2008 and the financial statements included
therein for the year ended December 31, 2008 together with all subsequent
filings made with the SEC available at the EDGAR website
("Reports").  Each Investor has been informed that to due to the
Company’s current lack of cash resources, it was unable to obtain a review by
our registered independent accountants of the interim financial statements for
the three-month period ended March 31, 2009 and the six-month period ended June
30, 2009.  In addition, each Investor may have received in writing
from the Company such other information concerning its operations, financial
condition and other matters as such Investor has requested in writing,
identified thereon as "Other Written Information" and considered all factors
such Investor deems material in deciding on the advisability of investing in the
Restricted Shares.

    

    4.2           Legal
Proceedings.

    

    4.2.1           Empire Asset
Management.   On December 9, 2008, Empire Asset Management
(“Empire”), a broker dealer that acted as the Company’s financial advisor and
exclusive placement agent and purchased stock for their own account in previous
private placement transactions, initiated a law suit against the Company in the
Supreme Court of the State of New York alleging that the Company misrepresented
the success of its business to induce Empire to invest in the
Company.  Empire is seeking compensatory damages in an unspecified
amount for the harm allegedly suffered.  The Company believes that the
action has no merit and intends to defend vigorously against the
action.

    

    4.2.2           Mr. David Berman. On
March 19, 2009, David Berman (“Berman”), an investor in the Company, initiated a
law suit against the Company in the Supreme Court of the State of New York
alleging that the Company misrepresented the success of its business to induce
Berman to invest in the Company.  Berman is seeking compensatory
damages in an unspecified amount for the harm allegedly suffered.  The
Company believes that the action has no merit and intends to defend vigorously
against the action.  

    

    5.           Representations, Warranties
and Covenants of the Company

    

    The
Company hereby represents, warrants and covenants as follows:

    

    5.1           Organization and
Qualification.      The Company is a corporation
duly organized, validly existing and in good standing under the laws of the
State of Delaware, and has the requisite corporate power to own its properties
and to carry on its business as it is now being conducted.

    

    5.2           Authorization,
Enforceability.  (i) The Company has the requisite corporate
power and authority to enter into this Agreement and to perform its obligations
hereunder  in accordance with the terms hereof, (ii) the execution and
delivery of this Agreement by the Company and the consummation by it of the
transactions contemplated hereby have been duly authorized by the Company’s
Board of Directors and further consent or authorization of the Company by its
Board of Directors is not required; and (iii) upon the execution and delivery of
this Agreement by the Company, this Agreement will constitute valid and binding
obligations of the Company enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of creditors’ rights and
remedies or by other equitable principles of general
application.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    

    5.3           Issuance of the Restricted
Shares.  The Restricted Shares to be issued, sold and delivered
by the Company hereunder, when so issued, sold and delivered, will be duly and
validly issued, fully paid and nonassessable and will be issued in reliance upon
applicable exemptions from the registration and qualification provisions of all
applicable securities laws of the United States and each state whose securities
laws may be applicable thereto.  All Restricted Shares will be issued
free of any preemptive or similar right and free and clear of any claim, lien,
security interest or other encumbrance.  Assuming the accuracy of the
Investors’ representations and warranties hereunder, the issuance to the
Investors of the Restricted Shares will be exempt from the registration
requirements of the Securities Act and will be made in reliance upon applicable
exemptions from the registration and qualification provisions of all applicable
state securities laws.

    

    [5.4           Registration
of the Restricted
Shares.           The
Company has no intention to register the Restricted Shares on behalf of the
Investors. ]

    

    6.           Representations, Warranties,
Acknowledgments, of the Investors

    

    Each
Investor hereby represents, warrants, acknowledges, understands and agrees (as
the case may be) to the following, and acknowledges that the Company's reliance
on exemption from registration pursuant to a registration statement under the
Securities Act of 1933, as amended (the “Securities Act”) is predicated upon the
representations of each Investor set forth herein:

    

    6.1           Authorization.  The
Investor has full power and authority to enter into this Agreement, and the
Agreement has been duly executed by the Investor, and such authorization
constitutes a valid and legally binding obligation of the Investor, enforceable
in accordance with its terms.

    

    6.2           The Restricted Shares Are
Not Registered.  The Investor hereby acknowledges that the
Restricted Shares will not be issued by the Company pursuant to a registration
statement under the Securities Act, and therefore the Investor may be required
to hold the Restricted Shares for an indeterminate period.  The
Restricted Shares are issued pursuant hereto in reliance upon a specific
exemption from the registration requirement of the Securities Act which depends,
in part, upon the accuracy of the representations, warranties, and agreements of
each Investor set forth in this Agreement.

    

    6.3           Investment
Intent.  The Investor is acquiring the Restricted Shares for
the Investor’s own account as principal, not as a nominee or agent, for
investment purposes only, and not with a view to, or for, resale, distribution
or fractionalization thereof, in whole or in part, which resale, distribution or
fractionalization would violate the Securities Act.  The Investor
agrees that a legend to the foregoing effect may be placed upon any and all
certificates issued representing the Restricted Shares.  Further, the
Investor does not have any contract, undertaking, agreement or arrangement with
any person to sell, transfer or grant participations to such person or to any
third person, with respect to the Restricted Shares, for which the Investor is
purchasing.  The Investor acknowledges that he has been afforded the
opportunity to ask questions of, and to obtain any information from, the Company
and the Board of Directors as he or she deems necessary to determine the
suitability and advisability of, and the merits and risk of, investing in the
Company pursuant hereto.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    6.4           Risk.  The
Investor is aware that: (i) investment in the Company involves a high degree of
risk, may result in a lack liquidity, and places substantial restrictions on
transferability of interest; and (ii) no Federal or state agency has made any
finding or determination as to the fairness for investment by the public, nor
has made any recommendation or endorsement, of the Restricted
Shares.

    

    6.5           Financial
Ability.  The Investor has sufficient financial resources
available to support the loss of all or a portion of Investor’s investment in
the Company, has no need for liquidity in the investment in the Company, and is
able to bear the economic risk of the investment.  The Investor is
sophisticated and experienced in investment matters, and, as a result, is in a
position to evaluate an investment in the Company.

    

    6.6           Information.  The
Investor has been furnished with any and all materials that he has requested
relating to the Company or the offering of the Restricted Shares, and the
Investor has been afforded the opportunity to ask questions of the senior
management and directors of the Company concerning the terms and conditions of
the offering and to obtain any additional information necessary to verify the
accuracy of the information provided to the Investor.  The Investor
understands that such material is current information about the Company and does
not in any way guarantee future performance or the completion of future proposed
events discussed in such material.  The Investor, either alone or with
his professional advisors, has the capacity to protect his own interests in
connection with this transaction.

    

    6.7           Regulation S
Exemption.  If the Investor is not a U.S. Person, the Investor
understands that that the Restricted Shares are being offered and sold to him in
reliance on an exemption from the registration requirements of United States
federal and the state securities laws under Regulation S promulgated under the
Securities Act, and that the Company is relying upon the truth and accuracy of
the representations, warranties, agreements, acknowledgments, and understandings
of the Investor to determine the applicability of such exemptions and the
suitability of the Investor to acquire the Restricted Shares.

    

    6.8           The
Investor consents to the Company making a notation on its records or giving
instructions to any transfer agent of the Company in order to implement the
restrictions on transfer of the Restricted Shares set forth in this Section
6.

    

    6.9           Legend.         The
certificates representing the Restricted Shares shall contain a legend
substantially as follows:

    

    “THE
SECURITIES WHICH ARE REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED,
HYPOTHECATED OR OTHERWISE DISPOSED OF UNTIL A REGISTRATION STATEMENT WITH
RESPECT THERETO IS DECLARED EFFECTIVE UNDER SUCH ACT, OR NEONODE, INC. RECEIVES
AN OPINION OF COUNSEL FOR THE HOLDER REASONABLY SATISFACTORY TO COUNSEL FOR
NEONODE, INC. THAT AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT
IS AVAILABLE.”

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    7.           Miscellaneous.

    

    7.1           Each
of the parties hereto shall perform such further acts and execute such further
documents as may reasonably be necessary to carry out and give full effect to
the provisions of this Agreement and the intentions of the parties as reflected
thereby.

    

    7.2           This
Agreement shall be governed by and construed according to the laws of the State
of New York, without regard to the conflict of laws provisions
thereof.

    

    7.3           Except
as otherwise expressly limited herein, the provisions hereof shall inure to the
benefit of, and be binding upon, the successors, assigns, heirs, executors, and
administrators of the parties hereto.

    

    7.4           This
Agreement and the Exhibits hereto constitute the full and entire understanding
and agreement between the parties with regard to the subject matters hereof and
thereof and supersede any prior agreement, understand or contract, written or
oral, with respect to the subject matter hereof and thereof.

    

    7.5           No
delay or omission to exercise any right, power, or remedy accruing to any party
upon any breach or default under this Agreement, shall be deemed a waiver of any
other breach or default theretofore or thereafter occurring. All remedies,
either under this Agreement or by law or otherwise afforded to any of the
parties, shall be cumulative and not alternative.

    

    7.6           If
any provision of this Agreement is held by a court of competent jurisdiction to
be unenforceable under applicable law, then such provision shall be excluded
from this Agreement and the remainder of this Agreement shall be interpreted as
if such provision were so excluded and shall be enforceable in accordance with
its terms; provided, however, that in such event this Agreement shall be
interpreted so as to give effect, to the greatest extent consistent with and
permitted by applicable law, to the meaning and intention of the excluded
provision as determined by such court of competent jurisdiction.

    

    7.7           This
Agreement may be executed in counterparts.

    

    IN WITNESS WHEREOF the parties have
signed this Convertible Note Agreement in one or more counterparts as of the
date first hereinabove set forth.

    

    
      For the Company:

      

      __________________:

      By:           ____________________

      Name:     
____________________

      Title:   
    ____________________

       

      For the
Investors:

    

    

    
      
        
          	
                  _______________

                	 
      	
                  _________________

                	 
      	
                  __________________

                	 
	 
      	 
      	 
      	 
      	 
      	 
	
                  By:

                	 
      	
                  By:

                	 
      	
                  By:

                	 

        

      

    

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    EXHIBIT
A

    

    LIST OF
INVESTORS

    

    
      	
              Investor:

            	
              Portion
      of

              Investment

              Amount

            	
              Address

            
	 
      	 
      	 
      

    

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    EXHIBIT
B

    

    CONVERTIBLE
NOTE

    
      	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	 
      	 
      

    

    
      
         

      

      
        8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]